A serious condition that may result in the worsening of existing health issues may be treated using direct acting antiviral (DAA) or hepatitis C drugs. The study was released in the American Journal of Epidemiology.
For the research, experts centered on national cohort of VA patients.
We recently conducted an exploratory study that indicated that several direct-acting antivirals (DAAs), highly effective medications for hepatitis C virus (HCV) infection, were also associated with improvement in posttraumatic stress disorder (PTSD) among a national cohort of US Department of Veterans Affairs (VA) patients treated between October 1, 1999, and September 30, 2019,” according to the study’s authors.
“While almost all patients were cured of HCV (92.5%) regardless of the agent received, PTSD outcomes were superior for those receiving GLE/PIB compared with those receiving LDV/SOF, indicating that GLE/PIB may merit further investigation as a potential PTSD treatment.”
The changes in PTSD symptoms were assessed using the PTSD Checklist after 8-12 weeks of DAA treatment.
The study was published online on June 11th, 2022.
